Kolexia
Armoiry Xavier
Pharmacien
Hôpital Edouard Herriot
Lyon, France
164 Activités
1.2 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Insuffisance mitrale Défaillance cardiaque Glioblastome Accident vasculaire cérébral Choc Choc cardiogénique Anévrysme intracrânien Anévrysme Tumeurs du cerveau

Industries

MARKET ACCESS TRANSFORMATION
71 collaboration(s)
Dernière en 2023
Lightning API Ltd
2 collaboration(s)
Dernière en 2020
Creativ-Ceutical SARL
1 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

EDELWEISS: Impact of a New Multiperfusion Neonatal System on Health and Cost of Care in Neonates
Essai Clinique (Hospices Civils de Lyon)   29 février 2024
A new perfusion system to reduce the burden of central venous line-associated bloodstream infections in neonates.
The Journal of hospital infection   17 octobre 2023
Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study.
Journal of neurosurgery   13 octobre 2023
Lower Limb Ischemia in Surgical Femoral Veno-Arterial Extracorporeal Membrane Oxygenation.
Journal of cardiothoracic and vascular anesthesia   24 juillet 2023
Potential impact on cost-effectiveness estimates of using immature survival data: a case study based on transcatheter edge-to-edge repair (TEER) used for patients with severe mitral regurgitation at high surgical risk.
BMJ open   14 mars 2023
ICSH guidance for INR and D-dimer testing using point of care testing in primary care.
International journal of laboratory hematology   07 mars 2023
Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair.
PloS one   26 janvier 2023
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis.
International journal of technology assessment in health care   13 décembre 2022
Évaluation de l’utilisation de pansements bactérioadsorbants dans un centre hospitalo-universitaire français
Le Pharmacien Clinicien   01 décembre 2022
Real-world data and evidence in health technology assessment: When are they complementary, substitutes, or the only sources of data compared to clinical trials?
Therapie   12 novembre 2022